Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Gail Weissman

Physician Assistant Brooklyn, NY Physician Assistant

NPI 1295327229 CMS profile 10758554

9413 Flatlands Ave Ste 102, Brooklyn, NY 11236

Open in the dashboard

General payments

$5,668

251 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Gail Weissman of Brooklyn, NY is reported in the CMS Open Payments database as having received $5,668 across 251 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,226 76
2024 General $2,747 84
2023 General $812 42
2022 General $556 34
2021 General $328 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gail Weissman
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Gail Weissman were reported at $1,226. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Gail Weissman Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $328 $132 $37–$438 $132
2022 $556 $155 $48–$522 $149
2023 $812 $167 $52–$557 $160
2024 $2,747 $178 $55–$600 $164
2025 $1,226 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Dermavant Sciences, Inc. $1,705 9 payments
  2. AbbVie, Inc. $984 81 payments
  3. Pfizer Inc. $533 37 payments
  4. Janssen Biotech, Inc. $461 22 payments
  5. UCB, Inc. $320 19 payments
  6. E.R. Squibb & Sons, L.L.C. $313 22 payments
  7. Sun Pharmaceutical Industries Inc. $271 12 payments
  8. Amgen Inc. $182 7 payments
  9. Incyte Corporation $164 9 payments
  10. Janssen Scientific Affairs, LLC $108 1 payment
  11. Other $627 32 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $4,043 248 payments
  2. Education $1,625 3 payments
Products named General payments · program years 2021–2025
  1. VTAMA $1,720 10 payments
  2. RINVOQ $793 70 payments
  3. TREMFYA $546 21 payments
  4. CIBINQO $495 35 payments
  5. LITFULO $474 34 payments
  6. Bimzelx $320 19 payments
  7. SOTYKTU $313 22 payments
  8. EUCRISA $278 17 payments
  9. Otezla $182 7 payments
  10. SKYRIZI $178 14 payments
  11. Other $1,053 60 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 24 drugs

Part D claims

1,139

Median for Physician Assistant: 241

Drug cost

$273,282

Median for Physician Assistant: $4,110

Branded share of claims

14.1%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Rinvoq Upadacitinib Brand 33 $206,799
Opzelura Ruxolitinib Phosphate Brand 16 $32,087
Clobetasol Propionate Generic 122 $4,987
Tacrolimus Generic 41 $4,878
Halobetasol Propionate Generic 74 $4,389
Metronidazole Generic 35 $3,505
Ketoconazole Generic 175 $3,150
Minoxidil Generic 53 $1,954
Mometasone Furoate Generic 61 $1,762
Tretinoin Generic 38 $1,475

The 10 drugs with the highest cost, of 24 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 16 billing codes

Paid by Medicare

$7,744

Of which drugs: $22

Medicare patients

41

Average age 68

Services billed

166

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 71%
Diabetes 41%
Arthritis 37%
Alzheimer's or dementia 0%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 18 38 $22

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 19 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
VTAMA
  • Dermavant Sciences, Inc. $1,483
$1,483 — —
RINVOQ
  • AbbVie, Inc. $305
$305 33 —
SOTYKTU
  • E.R. Squibb & Sons, L.L.C. $296
$296 — —
Otezla
  • Amgen Inc. $95
$95 — —
ILUMYA
  • Sun Pharmaceutical Industries Inc. $68
$68 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 19 in the dashboard with a free account

Records

251 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record